Moderna, Inc. Dividend History (MRNA)
Moderna, Inc. does not pay dividends currently 😔
They might in the future, check back soon!
About Moderna, Inc.
Moderna, Inc. is a pioneering biotechnology company, founded in 2010, that focuses on developing and commercializing messenger RNA (mRNA) therapeutics and vaccines. With its headquarters in Cambridge, Massachusetts, Moderna gained significant global attention for its role in developing one of the first COVID-19 vaccines, known as Spikevax. The company was co-founded by Derrick Rossi and is currently led by CEO Stéphane Bancel. Moderna's innovative approach centers on using mRNA to direct the body's cells to produce proteins that can prevent or treat diseases, positioning it as a leader in mRNA technology. As of 2022, the company reported a revenue of over $18 billion, reflecting its pivotal role in the pandemic response. Moderna continues to expand its research and development efforts in diverse areas, including rare diseases, oncology, and personalized medicine.
The article discusses the worst-performing stocks in the Nasdaq-100 index so far in 2022, emphasizing that investors should not abandon long-term investments due to short-term slumps. It suggests considering the underlying reasons for the price declines and maintaining a long-term perspective.
The Motley Fool · Published on Tue Nov 26 2024Rosen Law Firm is encouraging Metagenomi, Inc. (MGX) investors to seek legal advice before the important November 25, 2024 deadline for a securities class action lawsuit. The lawsuit alleges that Metagenomi misled investors about its business relationship with Moderna during its IPO.
GlobeNewswire Inc. · Published on Mon Nov 25 2024Rosen Law Firm reminds Metagenomi, Inc. investors of the November 25, 2024 deadline to join a securities class action lawsuit against the company. The lawsuit alleges that Metagenomi misled investors about its business relationship with Moderna during its IPO.
GlobeNewswire Inc. · Published on Fri Nov 22 2024